OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 58 filers reported holding OVID THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,835,000 | -62.2% | 1,540,671 | -55.8% | 1.27% | -63.5% |
Q2 2022 | $7,499,000 | -43.4% | 3,487,928 | -17.3% | 3.49% | -36.5% |
Q1 2022 | $13,245,000 | +3.0% | 4,218,069 | +5.3% | 5.49% | -6.9% |
Q4 2021 | $12,860,000 | +17.7% | 4,006,185 | +23.2% | 5.90% | +18.6% |
Q3 2021 | $10,930,000 | +39.8% | 3,252,892 | +62.6% | 4.97% | +21.6% |
Q2 2021 | $7,820,000 | -21.7% | 2,000,000 | -19.5% | 4.09% | -24.2% |
Q1 2021 | $9,982,000 | – | 2,483,059 | – | 5.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,000,000 | $7,820,000 | 4.09% |
BVF INC/IL | 6,631,051 | $25,927,000 | 0.97% |
EcoR1 Capital, LLC | 6,082,200 | $23,781,000 | 0.89% |
GLOBEFLEX CAPITAL L P | 1,009,125 | $3,946,000 | 0.71% |
Ikarian Capital, LLC | 1,124,872 | $4,398,000 | 0.36% |
CHI Advisors LLC | 218,510 | $854,000 | 0.20% |
Artal Group S.A. | 2,500,000 | $9,775,000 | 0.20% |
DCF Advisers, LLC | 139,701 | $546,000 | 0.19% |
Tibra Equities Europe Ltd | 78,700 | $308,000 | 0.10% |
XTX Topco Ltd | 50,569 | $198,000 | 0.07% |